Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation

• Rolf Burghaus,

  Affiliation Bayer Schering Pharma AG, Wuppertal, Germany

  ⨯
• Katrin Coboeken,

  Affiliation Bayer Technology Services GmbH, Leverkusen, Germany

  ⨯
• Thomas Gaub,

  Affiliation Bayer Technology Services GmbH, Leverkusen, Germany

  ⨯
• Lars Kuepfer,

  Affiliation Bayer Technology Services GmbH, Leverkusen, Germany

  ⨯
• Anke Sensse,

  Affiliation Bayer Schering Pharma AG, Berlin, Germany

  ⨯
• Hans-Ulrich Siegmund,

  Affiliation Bayer Technology Services GmbH, Leverkusen, Germany

  ⨯
• Wolfgang Weiss,

  Affiliation Bayer Technology Services GmbH, Leverkusen, Germany

  ⨯
• Wolfgang Mueck,

  Affiliation Bayer Schering Pharma AG, Wuppertal, Germany

  ⨯
• Joerg Lippert

  * E-mail: joerg.lippert@bayer.com

  Affiliation Bayer Technology Services GmbH, Leverkusen, Germany

  ⨯